COMPARATIVE STUDY OF TREATMENT OF CHRONIC AND RECURRENT DERMATOPHYTOSIS - RANDOMIZED CLINICAL TRIAL

Efficacy of combination of griseofulvib with fluconazole against griseofulvin alone for the treatment of chronic and recurrent dermatophytosis-randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/053261

Enrollment

100

Registered

2023-05-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: EFFICACY OF COMBINATION OF GRISEOFULVIN WITH FLUCONAZOLE AGAINST GRISEOFULVIN ALONE FOR THE TREATMENT OF CHRONIC AND RECURRENT DERMATOPHYTOSIS - RANDOMIZED CLINICAL TRIAL: A recent

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 years and above Gender irrespective Clinical cases of Tinea corporis ,Tinea cruris, Tinea faciei or Tinea glutealis and combination of any of these conditions fitting within the definition of chronic/recurrent dermatophytosis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cure rates ll be assessed as outcome Clearance of lesions Reduction in erythema, itching, scaling Timepoint: Base line 4 weeks 8 weeks	—

Secondary

Measure	Time frame
Proportion of chronic and recurrent dermatophytosis and correlation of clinical picture and failure rates Relapse rates between combination and monotherapy Drug safety profile Timepoint: 8 weeks	—

Countries

India

Contacts

Public ContactArulmozhi Rajan

Tirunelveli medical college

nirmaladevipalanivel@gmail.com9843291235

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026